• Enhances solubility of active pharmaceutical ingredients with poor bioavailability • Enables higher amount of API loading with excellent stability Billerica, Massachusetts, December 2, 2016 - MilliporeSigma, a leading science and technology ... BioSpace, 1 day ago
Merck Launches Parteck® MXP Excipient for Increased Solubility - PharmiWeb, 1 day ago
MERCK : Launches Parteck® MXP Excipient for Increased Solubility - 4 Traders, 1 day ago
Published: 21 November 2016 - Rachel Tucker November 8th - 10th saw the annual National Buying Group Conference held at The Celtic Manor in Newport, Wales. The awards had 10 categories, with winners and runners up as follows: Brick & Block ...Builders Merchants Journal, 1 week ago
Multinational survey of pharma execs offers insight on pharmaceutical companies growth strategies and risk management in the challenging biologics landscape By Andrew Bulpin, vice president, Process Solutions, Merck KGaA Nov 12, 2016 As ...Pharmaceutical Manufacturing Magazine, 3 weeks ago
0 It might surprise you to learn that XenServer recently marked its 10th year anniversary of commercially available releases (an eventcovered very well in a recent blog post fromJames Bulpin). The early releases of XenServer ...DABCC, 1 month ago
Posted Date: 10/7/2016 MilliporeSigma recently launched the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams. The new Viresolve Pro Shield H is designed for use as a prefilter with Viresolve Pro Devices ...Drug Development & Delivery, 1 month ago
on your WebpageAdd Widget >Get your members hooked!